Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors.

Jiang Y, Cao H, Deng H, Guan L, Langthasa J, Colburg DRC, Melemenidis S, Cotton RM, Aleman J, Wang XJ, Graves EE, Kalbasi A, Pu K, Rao J, Le QT

Open source

DOI: 10.1038/s41587-024-02448-0
Published: 2025 Sep
Container: Nature biotechnology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41587-024-02448-0,
  title = {Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors.},
  author = {Jiang Y and Cao H and Deng H and Guan L and Langthasa J and Colburg DRC and Melemenidis S and Cotton RM and Aleman J and Wang XJ and Graves EE and Kalbasi A and Pu K and Rao J and Le QT},
  year = {2025},
  journal = {Nature biotechnology},
  doi = {10.1038/s41587-024-02448-0},
  url = {https://doi.org/10.1038/s41587-024-02448-0}
}

RIS

TY  - JOUR
TI  - Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors.
AU  - Jiang Y
AU  - Cao H
AU  - Deng H
AU  - Guan L
AU  - Langthasa J
AU  - Colburg DRC
AU  - Melemenidis S
AU  - Cotton RM
AU  - Aleman J
AU  - Wang XJ
AU  - Graves EE
AU  - Kalbasi A
AU  - Pu K
AU  - Rao J
AU  - Le QT
PY  - 2025
JO  - Nature biotechnology
DO  - 10.1038/s41587-024-02448-0
UR  - https://doi.org/10.1038/s41587-024-02448-0
ER  -

APA

Y, J., H, C., H, D., L, G., J, L., DRC, C., S, M., RM, C., J, A., XJ, W., EE, G., A, K., K, P., J, R., & QT, L. (2025). Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors.. Nature biotechnology. https://doi.org/10.1038/s41587-024-02448-0

Source records

pubmed · retrieved 2026-09-26T13:10:09.695Z